Cipla receives USFDA warning on GMP violations; analysts remain bullish
Pharmaceutical giant Cipla has received a warning letter from the United States Food and Drug Administration (USFDA) as part
Continue reading
Tag: Drug manufacturer
The Number One Finance & Business Blog!